§ Funding Round
Series B funding round for Gilgamesh Pharmaceuticals raising $39M in December 2022
Series B funding round for Gilgamesh Pharmaceuticals raising $39M in December 2022
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$88.2M
Top Valuation
-
Gilgamesh Pharmaceuticals raised $39M in a Series B round.
The round was announced on 12/01/22.
The round was led by amy kruse.
